| ²é¿´: 10498 | »Ø¸´: 4 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
´óÀÁ³æ1106ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
nature medicine Ͷ¸åÌá½»ºó£¬·¢ÐÅÈÃдһ¸öchecklist£¬ÇëÓоÑéµÄ³æ³æ°ï°ïæѽ
|
||
|
ÈçÌ⣬ÒòΪÔÀ´Ã»ÓÐͶ¹ýÕâÖÖҽѧÀàµÄÔÓÖ¾£¬Ò²Ã»ÓÐÌî¹ýÕâÖÖÀàËÆµÄÇåµ¥£¬ÇëÓþÑéµÄ³æ³æ°ï°ïæ 1¡¢¸Ã¸å¼þÊÇ´Ónature chemistryÖ±½Óͨ¹ýϵͳתͶµ½nature medicineÉϵģ¬±à¼²¿Í¨¹ýÓʼþ·¢ÏÖÈÃÌîдÕâ¸öÇåµ¥£¬ÓʼþÔÎÄÈçÏ£º As you may know, we are trying to improve the quality and transparency of methods and statistics reporting in our papers (http://www.nature.com/nm/journal/v19/n5/full/nm0513-508.html). To that end, we now require authors to fill out a checklist (available at: http://www.nature.com/authors/policies/checklist.pdf ) to confirm that all relevant elements have been included in the manuscript. Please note that we will only use this checklist if the editors decide to send your article for external review. However, to avoid any unnecessary delays in the handling of your papers, we encourage you to fill the checklist during the journal�??s internal review of the paper. ÇëÎÊÕâ¸ö ÔõôÌîд£¿ÌîÍêÖ®ºóͨ¹ýÓʼþ·¢¹ýÈ¥Â𣿻¹ÊÇͨ¹ýͶ¸åϵͳ£¿Òò¸Ã¸å¼þʱͨ¹ýnatureϵͳ×Ô¶¯×ªÍ¶µ½nature medicineÉϵ쬲»ÖªµÀÕâÖÖ״̬ÏÂÒª´ÓÄÄÀïÌá½»Õâ¸öchecklist£¿ÇóÖ¸½Ì¡£ 2¡¢nature medicineÒ»°ã¶à¾ÃÄÜËÍÉó£¬ËÍÉóÖ®ºó»á·¢ÐÅ֪ͨÂð£¿Ò»Éóʱ¼äʱ¶à¾Ã£¿ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : checklist_(1).pdf
2013-06-14 09:50:06, 125.01 K
» ²ÂÄãϲ»¶
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ18È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ12È˻ظ´
ÓÐûÓÐÈÔûÊÕµ½ÐÅÏ¢µÄ
ÒѾÓÐ3È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ8È˻ظ´
»ù½ð²»ÖУ¬¹²Ãã
ÒѾÓÐ11È˻ظ´
Â鷳ר¼ÒÃÇ¿´¿´ÆÀίÃǵÄÒâ¼û£¨F¿ÚÃæÉÏ£©
ÒѾÓÐ9È˻ظ´
2026ÄêÒ¶ÆóËï»ù½ð
ÒѾÓÐ6È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ13È˻ظ´
»ù½ðϵͳʲôÄÚÈÝҲûÓÐ
ÒѾÓÐ9È˻ظ´
Ôõô²é°¡
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúBMCµÄCHECKLIST FOR COMPOUND CHARACTERIZATIONÔõôд
ÒѾÓÐ5È˻ظ´
Submission ChecklistÖеÄÒ»¸ö¿Õ
ÒѾÓÐ10È˻ظ´
ÇëÎÊ ElsevierͶ¸å×îºóÐèÒªµÝ½»CHECKLIST£¬Õâ¸öÊǸÉɶµÄ°¡£¿
ÒѾÓÐ14È˻ظ´
Ð޸ĸåͶ³öÈ¥Ò»¸öÀñ°ÝÁËÁË»¹ÊÇ Awaiting EO Checklist
ÒѾÓÐ8È˻ظ´
hkhl4633
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 607.4
- É¢½ð: 60
- ºì»¨: 4
- Ìû×Ó: 60
- ÔÚÏß: 59.2Сʱ
- ³æºÅ: 521122
- ×¢²á: 2008-03-08
- ÐÔ±ð: MM
- רҵ: ϸ°ûÉúÎïѧ
| ÎÒÒ²Óöµ½ÏàͬµÄÎÊÌ⣬ÇëÎÊÂ¥Ö÷×îºóÔõôÌîµÄ¡£¿´Á˰ëÌì²»ÖªµÀÔõôÌºÃ¶à¶¼ÊÇûÓÐÉæ¼°µ½µÄ£¬¿Õ×ÅÅ·¢»ØÈ¥Ó°ÏìÎÄÕÂËÍÉó¡£ |
3Â¥2015-11-04 21:02:52
ºÌÎÄϧ
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 47 (СѧÉú)
- ½ð±Ò: 351.3
- ºì»¨: 1
- Ìû×Ó: 199
- ÔÚÏß: 31Сʱ
- ³æºÅ: 988575
- ×¢²á: 2010-04-03
- ÐÔ±ð: MM
- רҵ: Ò©ÀíѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
ÕâÖÖÒ»°ãÊÇÉÏ´«µ½ÏµÍ³Éϵģ¬Äã¿ÉÒÔÓÃÕË»§µÇ¼µ½ÏµÍ³ÏȲ鿴һÏÂÊÇ·ñÊÇ¿ÉÒÔÉÏ´«Ð޸ĵÄ״̬£¬¾ÍÊÇunsubimt£» Èç¹ûÊǵ쬾ÍÔÚϵͳÉÏ´«¡£Èç¹ûÏÔʾunder review£¬ÄǾÍÊǵÃÓʼþ»Ø¸´ÁË¡£Éó¸åʱ¼äÒ»°ãÊÇ2¸öÔ¡£µ«ÊÇÉó¸åÈ˸öÈ˲îÒì±È½Ï´ó£¬Ò²ÓÐ6¸öÔÂ×óÓҵġ£2¸öÔºó¿ÉÒÔ·¢´ß¸åÐÅ×Éѯ¡£ |

2Â¥2013-06-14 09:55:21
hkhl4633
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 607.4
- É¢½ð: 60
- ºì»¨: 4
- Ìû×Ó: 60
- ÔÚÏß: 59.2Сʱ
- ³æºÅ: 521122
- ×¢²á: 2008-03-08
- ÐÔ±ð: MM
- רҵ: ϸ°ûÉúÎïѧ
| ÎÒÒ²Óöµ½ÏàͬµÄÎÊÌ⣬ÇëÎÊÂ¥Ö÷×îºóÔõôÌîµÄ¡£¿´Á˰ëÌì²»ÖªµÀÔõôÌºÃ¶à¶¼ÊÇûÓÐÉæ¼°µ½µÄ£¬¿Õ×ÅÅ·¢»ØÈ¥Ó°ÏìÎÄÕÂËÍÉó¡£ |
4Â¥2015-11-04 21:03:10
84146922
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 42 (СѧÉú)
- ½ð±Ò: 860.2
- É¢½ð: 185
- ºì»¨: 1
- Ìû×Ó: 245
- ÔÚÏß: 114.5Сʱ
- ³æºÅ: 1888599
- ×¢²á: 2012-07-11
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒÅ´«ÓýÖÖѧ
|
ÄãºÃ£¬ÇëÎÊÄãÌîÁËÕâ¸ölistÂ𣿣¿ Is the variance similar between the groups that are being statistically compared? Õâ¾ä»°Ö¸µÄ·½²îÏàËÆ£¬ÐèÒªÓ÷½²îÆëÐÔ·ÖÎö£¬»¹ÊÇÆäËû·ÖÎöÄØ£¿£¿ лл |
5Â¥2017-10-18 15:15:09









»Ø¸´´ËÂ¥
30